Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Angiopoietins Promote Ovarian Cancer Progression by Establishing a Procancer Microenvironment
Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions
Angiotensin II mediates urotensin II expression by hypoxia in cultured cardiac fibroblast
Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks
Angiotensin AT(1) receptor blockers suppress oxidized low-density lipoprotein-derived formation of foam cells
Angiogenesis in Hepatocellular Carcinoma: A Potential Target for Chemoprevention and Therapy
Angiotensin-I-converting enzyme and prolyl endopeptidase inhibitory peptides from natural sources with a focus on marine processing by-products
Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients
Angiogenesis and scar formation in healing wounds
Angiotensin II Decreases Nitric Oxide Synthase 3 Expression via Nitric Oxide and Superoxide in the Thick Ascending Limb
Angiotensin II Contributes to Diabetic Renal Dysfunction in Rodents and Humans via Notch1/Snail Pathway
AngiomiRs-Key regulators of angiogenesis
AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics
Angiogenesis within the duodenum of patients with cirrhosis is modulated by mechanosensitive Kruppel-like factor 2 and microRNA-126
Angiogenesis is controlled by miR-27b associated with endothelial tip cells
Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension
Angiogenic response pattern during normal and impaired skin flap re-integration in mice: A comparative study
Angiotensin-converting enzyme inhibition curbs tyrosine nitration of mitochondrial proteins in the renal cortex during the early stage of diabetes mellitus in rats
Angiotensin-converting enzyme 2 polymorphisms and cardiovascular risk
Angiographic Demonstration of Neoangiogenesis After Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Diabetic Patients With Critical Limb Ischemia
Angiotensin Converting Enzyme Inhibitors Mitigate Collagen Synthesis Induced by a Single Dose of Radiation to the Whole Thorax
Angiotensin II as a factor modulating protein tyrosine kinase activity in two breast cancer lines - MCF-7 and MDA-MB-231
Angina pectoris without coronary stenosis - current concepts
Angiotensin II stimulates in vitro branching morphogenesis of the isolated ureteric bud
Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes
Angiogenesis in the pathogenesis of pterygium
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappa B and Elk-1 in neurons
Angiotensin inhibition and malignancies: a review
Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
Angiotensin converting enzyme is involved in the cardiac hypertrophy induced by sinoaortic denervation in rats
Angiogenin-Induced tRNA Fragments Inhibit Translation Initiation
Angiogenin cleaves tRNA and promotes stress-induced translational repression
Angiomatosis and Ectopic Ossification in the Dog Myocardium after Intramyocardial Implantation of Autologous Bone Marrow Mononuclears in Experimental Coronary Disease
Angiographic Vasospasm Is Strongly Correlated With Cerebral Infarction After Subarachnoid Hemorrhage
Angiogenic Cell Therapy for Severe Ischemic Diseases
Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling
Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure
Angiomyolipoma of the colon: Report of a case
Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders
Angiogenic inhibitors and radiotherapy: From the concept to the clinical trial
Angiographic Classification and Sclerotic Therapy of Maxillofacial Cavernous Haemangiomas: a Report of 204 Cases
Angiogenesis Detection in Cerebral Arteriovenous Malformations: Mediators and Gene Expression, and Treatment Hopes for the Future
Angiopoietins, abdominal aortic aneurysm and atherosclerosis
Angiogenesis in Synchronous and Metachronous Colorectal Liver Metastases The Liver as a Permissive Soil
Angiogenesis and inflammatory response in endometriosis
Angiotensin AT(2) receptor agonists act as anti-opioids via EP(3) receptor in mice
Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis
Angiogenic Factors and Preeclampsia
Angiopoietin-1 but not angiopoietin-2 promotes neutrophil viability: Role of interleukin-8 and platelet-activating factor
Angiogenesis in Non-small Cell Lung Cancer Imaging With Perfusion Computed Tomography
Angiotensin converting enzyme DD genotype is associated with development of rheumatic heart disease in Egyptian children
Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning
Angiogenin up-regulation correlates with adverse clinicopathological and biological factors, increased microvascular density and poor patient outcome in neuroblastomas
Angiogenic Remodeling in Pediatric EoE Is Associated With Increased Levels of VEGF-A, Angiogenin, IL-8, and Activation of the TNF-alpha-NF kappa B Pathway
Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients
Angiogenin expression in head and neck basaloid and conventional squamous cell carcinoma: a site- and stage-matched comparison
Angiogenin induces nitric oxide release independently from its RNase activity
Angiogenin in age-related macular degeneration
Angiogenesis in cutaneous disease: Part I
Angiogenesis in cutaneous disease: Part II
Angiosarcoma of the breast and vascular endothelial growth factor receptor
Angiotensin II-Dependent Hypertension Requires Cyclooxygenase 1-Derived Prostaglandin E-2 and EP1 Receptor Signaling in the Subfornical Organ of the Brain
Angiostatin K1-3 induces E-selectin via AP1 and Ets1: a mediator for anti-angiogenic action of K1-3
Angiotensin II Type 2 Receptor Stimulation Initiated After Stroke Causes Neuroprotection in Conscious Rats
Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche
Angiotensin II type 1 receptor blockers: class effects versus molecular effects
Angiotensin II type 1 receptor mediates partially hyposmotic-induced increase of I (Ks) current in guinea pig atrium
Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: A meta-analysis and meta-regression of randomised controlled trials
Angiotensin II Enhances Interleukin-1 beta-Induced MMP-9 Secretion in Adult Rat Cardiac Fibroblasts
Angiotensin II stimulates canonical TGF-beta signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction
Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats
Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
Angiomotin is a novel component of cadherin-11/beta-catenin/p120 complex and is critical for cadherin-11-mediated cell migration
Angiosperm divergence times: The effect of genes, codon positions, and time constraints
Angiogenesis and hepatocellular carcinoma
Angiogenic Microvascular Endothelial Cells Release Microparticles Rich in Tissue Factor That Promotes Postischemic Collateral Vessel Formation
Angiogenesis A Harmonized Target for Recovery After Stroke
Angiopoietin-like Protein 2 Promotes Chronic Adipose Tissue Inflammation and Obesity-Related Systemic Insulin Resistance
Angiogenesis Modulation-The "Spice Effect"
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy
Angiogenesis inhibition and lung-cancer therapy
Angiogenesis inhibitor TNP-470 can suppress hepatocellular carcinoma growth without retarding liver regeneration after partial hepatectomy